Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
158
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence

Ming-Jr Jian1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Hsing-Yi Chung1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Chih-Kai Chang1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Jung-Chung Lin2 Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Kuo-Ming Yeh2 Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Chien-Wen Chen3 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Shih-Yi Li1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Shan-Shan Hsieh1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Ming-Tsan Liu4 Centers for Disease Control, Taipei, Taiwan, Republic of China
,
Ji-Rong Yang4 Centers for Disease Control, Taipei, Taiwan, Republic of China
,
Sheng-Hui Tang1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Cherng-Lih Perng1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
,
Feng-Yee Chang2 Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
&
Hung-Sheng Shang1 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-4831-1866
ORCID Icon show all
Pages 3255-3261 | Published online: 17 Aug 2021

References

  • WuZ, McGooganJM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–1242. doi:10.1001/jama.2020.264832091533
  • The Lancet. Emerging understandings of 2019-nCoV. Lancet. 2020;395(10221):311. doi:10.1016/S0140-6736(20)30186-031986259
  • XieM, ChenQ. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020;94:119–124. doi:10.1016/j.ijid.2020.03.07132247050
  • RussoA, MinichiniC, StaraceM, et al. Current status of laboratory diagnosis for COVID-19: a narrative review. Infect Drug Resist. 2020;13:2657–2665. doi:10.2147/IDR.S26402032801804
  • MostafaHH, HardickJ, MoreheadE, MillerJA, GaydosCA, ManabeYC. Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. J Clin Virol. 2020;130:104578. doi:10.1016/j.jcv.2020.10457832777761
  • CaruanaG, CroxattoA, CosteAT, et al. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clin Microbiol Infect. 2020;26:1178–1182. doi:10.1016/j.cmi.2020.06.01932593741
  • ChungHY, JianMJ, ChangCK, et al. Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system. Emerg Microbes Infect. 2021;10:161–166. doi:10.1080/22221751.2021.187307333410371
  • ZhenW, SmithE, ManjiR, SchronD, BerryGJ. Clinical evaluation of three sample-to-answer platforms for the detection of SARS-CoV-2. J Clin Microbiol. 2020;58:e00783–20. doi:10.1128/JCM.00783-2032332061
  • LoeffelholzMJ, TangYW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020;9:747–756. doi:10.1080/22221751.2020.174509532196430
  • SmithE, ZhenW, ManjiR, SchronD, DuongS, BerryGJ. Analytical and clinical comparison of three nucleic acid amplification tests for SARS-CoV-2 detection. J Clin Microbiol. 2020;58:e01134–20. doi:10.1128/JCM.01134-2032571894
  • PokhrelP, HuC, MaoH. Detecting the Coronavirus (COVID-19). ACS Sens. 2020;5:2283–2296. doi:10.1021/acssensors.0c0115332627534
  • OisheeMJ, AliT, JahanN, et al. COVID-19 pandemic: review of contemporary and forthcoming detection tools. Infect Drug Resist. 2021;14:1049–1082. doi:10.2147/IDR.S28962933762831
  • BoehmE, KronigI, NeherRA, et al. Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect. 2021. doi:10.1016/j.cmi.2021.05.022
  • LeungK, ShumMHH, LeungGM, LamTTY, WuJT. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Eurosurveillance. 2021;26:2002106. doi:10.2807/1560-7917.ES.2020.26.1.2002106
  • JianMJ, ChungHY, ChangCK, et al. Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system. Clin Chim Acta. 2021;514:54–58. doi:10.1016/j.cca.2020.12.00333316217
  • JianMJ, ChungHY, ChangCK, et al. Investigation of one familial cluster of COVID-19 in Taiwan: differentiation of genetic variation among isolates and implications for epidemiological investigation and surveillance by genomic assay. Infect Drug Resist. 2021;14:971–977. doi:10.2147/IDR.S29845133737819
  • CradicK, LockhartM, OzboltP, et al. Clinical evaluation and utilization of multiple molecular in vitro diagnostic assays for the detection of SARS-CoV-2. Am J Clin Pathol. 2020;154:201–207. doi:10.1093/ajcp/aqaa09732462195
  • VashistSK. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics. 2020;10(4):202.
  • Perez-LopezB, MirM. Commercialized diagnostic technologies to combat SARS-CoV2: advantages and disadvantages. Talanta. 2021;225:121898. doi:10.1016/j.talanta.2020.12189833592692
  • MaL, WangW, Le GrangeJM, et al. Coinfection of SARS-CoV-2 and other respiratory pathogens. Infect Drug Resist. 2020;13:3045–3053. doi:10.2147/IDR.S26723832922049
  • NowakMD, SordilloEM, GitmanMR, Paniz MondolfiAE. Co-infection in SARS-CoV-2 infected poatients: where are influenza virus and rhinovirus/enterovirus?J Med Virol. 2020;92:1699–1700. doi:10.1002/jmv.2595332352574
  • WuX, CaiY, HuangX, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26:1324–1326. doi:10.3201/eid2606.20029932160148
  • CreagerHM, CabreraB, SchnaubeltA, et al. Clinical evaluation of the BioFire(R) Respiratory Panel 2.1 and detection of SARS-CoV-2. J Clin Virol. 2020;129:104538. doi:10.1016/j.jcv.2020.10453832650276

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.